Loading clinical trials...
Loading clinical trials...
There is a lack of data on clinical and patient factors that are associated with poor survival in patients with HR+ and HER2-low/negative breast cancer treated with neoadjuvant chemotherapy or endocri...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Daiichi Sankyo
NCT06257264 · Breast Cancer, Small Cell Lung Cancer, and more
NCT07218432 · Breast Cancer Stage I, Breast Cancer Stage II, and more
NCT05467891 · Locoregional Recurrence, Hormone Receptor-positive Breast Cancer, and more
NCT05660083 · HER2-negative Breast Cancer, Metastatic Breast Cancer, and more
NCT07483307 · Breast Cancer, HER2-negative Breast Cancer, and more
ConcertAI database
Cambridge, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions